Robyn is taking part in pretty muddy with some of her friends, where they're going to get - Muddy for Megan. Sadly Megan died on 2 January 2019 just three weeks after being diagnosed with type three Pleuropulmonary Blastoma – a rare and aggressive form of lung cancer found in children. She was only 2 years, 11 months and 6 days old when she passed. Robyn wants to do something for others while she tries to get her head around life without her little cousin Megan. Robyn talks about Megan daily and cuddles tightly Megan's bunny toy Lily every night. We hope these funds go towards earlier diagnosis of childhood cancer.
Robyn's Race for Life
Robyn Clarkson
Total raised
£800.00
+ £176.25 Gift Aid
320% of £250.00 target
Donating through this page is simple, fast and totally secure. Your details are safe with Cancer Research UK
Robyn and friends are taking part in Pretty Muddy to raise money to help beat cancer sooner. She's raising money in memory of Megan, her 2 year old cousin who we lost on January 2nd 2019.
In memory of
Megan, Robyns little cousin
My gallery
Latest updates
S
Sarah Morrison
2019-06-16T12:40:40+00:00
£15.00
R
Ruth Tullis
2019-06-15T16:38:27+00:00
£20.00
+£5.00 Gift Aid
L
Lorraine Evans
2019-06-15T15:33:08+00:00
£10.00
+£2.50 Gift Aid
S
Susan Taylor
2019-06-15T11:52:47+00:00
£5.00
+£1.25 Gift Aid
K
Keith Crombie
2019-06-15T11:15:07+00:00
£10.00
+£2.50 Gift Aid
S
Silvana Hanvey
2019-06-15T10:26:18+00:00
£10.00
+£2.50 Gift Aid
Total raised£800.00
Online£800.00
Offline£0.00
With Cancer Research UK Giving Pages more of the money raised goes towards beating cancer sooner. Aside from the credit and debit card fees, every penny donated goes to Cancer Research UK.
All donations made to this page will automatically be transferred to Cancer Research UK.
Cause
Childhood cancer
Each year, around 1,500 children are diagnosed with cancer in the UK. Thanks to major advances in research, around three-quarters of children with cancer now survive. Help Cancer Research UK discover better and kinder treatments for all cancers and to continue to improve overall survival for childhood cancer.
